Blood transfusion and alternatives in Jehovah's Witness patients.
Journal
Current opinion in anaesthesiology
ISSN: 1473-6500
Titre abrégé: Curr Opin Anaesthesiol
Pays: United States
ID NLM: 8813436
Informations de publication
Date de publication:
01 Apr 2021
01 Apr 2021
Historique:
pubmed:
13
2
2021
medline:
6
3
2021
entrez:
12
2
2021
Statut:
ppublish
Résumé
More than 8.5 million people in the world observe the Jehovah's Witness faith, and require unique consideration for perioperative blood management as they generally refuse transfusion of blood and blood products. This review addresses a collaborative approach to each patient throughout the perioperative arena. The principles of this approach include optimization of hemoglobin levels preoperatively, attention to blood-salvaging methods intraoperatively, and minimization of blood draws postoperatively. In addition, we review the technologies currently in development as transfusion alternatives, including hemoglobin-based oxygen carriers. Progress has been made recently in the field of synthetic blood alternatives and hemoglobin-based oxygen carriers, which may lead to improved outcomes in this patient population. Utilization of multiple prevention and mitigation strategies to optimize oxygen supply and decrease oxygen demand will lead to decreased incidence of critical anemia and subsequent improved mortality in Jehovah's Witness patients.
Identifiants
pubmed: 33577206
doi: 10.1097/ACO.0000000000000961
pii: 00001503-202104000-00011
doi:
Substances chimiques
Hemoglobins
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
125-130Informations de copyright
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Références
Posluszny JA, Napolitano LM. Hemoglobin-based oxygen carrier for traumatic hemorrhagic shock treatment in a Jehovah's Witness. Arch Trauma Res 2016; 5:e30610.
McConachie S, Wahby K, Almadrahi Z, Wilhelm S. Early experiences with PEGylated carboxyhemoglobin bovine in anemic Jehovah's Witnesses: a case series and review of the literature. J Pharm Pract 2020; 33:372–377.
Mason CL, Tran CK. Caring for the Jehovah's Witness parturient. Anesth Analg 2015; 121:1564–1569.
Crowe EP, DeSimone RA. Transfusion support and alternatives for Jehovah's Witness patients. Curr Opin Hematol 2019; 26:473–479.
How many of Jehovah's Witnesses are there worldwide? [Internet]. Available at: https://www.jw.org/en/jehovahs-witnesses/faq/how-many-jw/ . [Accessed 7 December 2020].
Marinakis S, Van der Linden P, Tortora R, et al. Outcomes from cardiac surgery in Jehovah's witness patients: experience over twenty-one years. J Cardiothorac Surg 2016; 11:67.
Müller H, Ratschiller T, Schimetta W, et al. Open heart surgery in Jehovah's Witnesses: a propensity score analysis. Ann Thorac Surg 2020; 109:526–533.
Lim C, Salloum C, Esposito F, et al. Safety and feasibility of elective liver resection in adult Jehovah's Witnesses: the Henri Mondor Hospital experience. HPB (Oxford) 2018; 20:823–828.
De Bellis M, Girelli D, Ruzzenente A, et al. Pancreatic resections in patients who refuse blood transfusions. The application of a perioperative protocol for a true bloodless surgery. Pancreatology 2020; 20:1550–1557.
Khalili M, Morano WF, Marconcini L, et al. Multidisciplinary strategies in bloodless medicine and surgery for patients undergoing pancreatectomy. J Surg Res 2018; 229:208–215.
Hardesty DA, Doerfler S, Sandhu S, et al. Bloodless’ neurosurgery among Jehovah's Witnesses: a comparison with matched concurrent controls. World Neurosurg 2017; 97:132–139.
Tan GM, Guinn NR, Frank SM, Shander A. Proceedings From the Society for Advancement of Blood Management Annual Meeting 2017: management dilemmas of the surgical patient-when blood is not an option. Anesth Analg 2019; 128:144–151.
Shander A, Goodnough LT. Management of anemia in patients who decline blood transfusion. Am J Hematol 2018; 93:1183–1191.
Klein AA, Bailey CR, Charlton A, et al. Association of Anaesthetists: anaesthesia and peri-operative care for Jehovah's Witnesses and patients who refuse blood. Anaesthesia 2019; 74:74–82.
Husarova V, Donnelly G, Doolan A, et al. Preferences of Jehovah's Witnesses regarding haematological supports in an obstetric setting: experience of a single university teaching hospital. Int J Obstet Anesth 2016; 25:53–57.
Rabinowitz MR, Cognetti DM, Nyquist GG. Blood-sparing techniques in head and neck surgery. Otolaryngol Clin North Am 2016; 49:549–562.
Klein MJ, Carter TI, Smith MC, et al. Prophylactic hypothermia and neuromuscular blockade to limit myocardial oxygen demand in a critically anemic Jehovah's Witness after emergency surgery†. J Surg Case Rep [Internet] 2014; 2014:1–3.
Binder RK, Barbanti M, Ye J, et al. Blood loss and transfusion rates associated with transcatheter aortic valve replacement: recommendations for patients who refuse blood transfusion. Catheter Cardiovasc Interv 2014; 83:E221–E226.
Dirk S, Manon R, Thomas K, Matthias D. Analysis of presurgical uterine artery embolization (puae) for very large uterus myomatosus; patient's desire to preserve the uterus; case series and literature review. RoFo: Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin 2014; 190:616–622.
Giulianotti PC, Addeo P, Bianco FM. Robotic right hepatectomy for giant hemangioma in a Jehovah's Witness. J Hepatobiliary Pancreat Sci 2011; 18:112–118.
Sumi K, Yoshida S, Okamura Y, Nakamura T. Staged open surgery for bicuspid aortic valve regurgitation and coarctation of the aorta in a Jehovah's witness. BMC Cardiovasc Disord 2020; 20:216.
Levent A, Köse Ö, Linke P, et al. Does tourniquet use decrease blood loss following primary total knee arthroplasty in Jehovah's Witness patients? Jt Dis Relat Surg 2020; 31:419–425.
DeRogatis M, Ozawa S, Feldman D. Use of the No Tourniquet Technique in Jehovah's Witness patients undergoing total knee arthroplasty. Bull Hosp Jt Dis 2020; 78:169–172.
Sanchez-Giron F, Alvarez-Mora F. Reduction of blood loss from laboratory testing in hospitalized adult patients using small-volume (pediatric) tubes. Arch Pathol Lab Med 2008; 132:1916–1919.
Posluszny JA Jr, Napolitano LM. How do we treat life-threatening anemia in a Jehovah's Witness patient? Transfusion 2014; 54:3026–3034.
Viele MK, Weiskopf RB. What can we learn about the need for transfusion from patients who refuse blood? The experience with Jehovah's Witnesses. Transfusion 1994; 34:396–401.
Czempik PF, Wojnarowicz O, Krzych ŁJ. Let us use physiologic transfusion triggers: favorable outcome in an 86-year-old Jehovah's witness with a haemoglobin nadir of 44 g l -1 . Transfus Apher Sci 2020; 59:102718.
Charles A, Purtill M, Napolitano LM. Recombinant human erythropoietin in severe anaemia: issues of dosing and duration. Anaesth Intensive Care 2006; 34:793–796.
Cooper L, Ford K, Miller E. Preparing a Jehovah's Witness for major elective surgery. BMJ 2013; 346:f1588.
Suh Y-S, Nho J-H, Choi H-S, et al. A protocol avoiding allogeneic transfusion in joint arthroplasties. Arch Orthop Trauma Surg 2016; 136:1213–1226.
Tobian AAR, Ness PM, Noveck H, Carson JL. Time course and etiology of death in patients with severe anemia. Transfusion 2009; 49:1395–1399.
Graffeo C, Dishong W. Severe blood loss anemia in a Jehovah's Witness treated with adjunctive hyperbaric oxygen therapy. Am J Emerg Med 2013; 31:756.e3–756.e4.
Salmen M, Hendriksen S, Gorlin J, et al. Oxygen delivery during severe anemia when blood transfusion is refused on religious grounds. Ann Am Thorac Soc 2017; 14:1216–1220.
Weber RS, Jabbour N, Martin RCG 2nd. Anemia and transfusions in patients undergoing surgery for cancer. Ann Surg Oncol 2008; 15:34–45.
Mauritz AA, Dominguez JE, Guinn NR, et al. Blood-conservation strategies in a blood-refusal parturient with placenta previa and placenta percreta. A A Case Rep 2016; 6:111–113.
Watch Tower Bible and Track Society of Pennsylvania. How Can Blood Save Your Life? 2001; Available at: https://www.jw.org/en/library/books/blood/ . [Accessed 4 December 2020].
McConachie SM, Almadrahi Z, Wahby KA, Wilhelm SM. Pharmacotherapy in acutely anemic Jehovah's Witnesses: an evidence-based review. Ann Pharmacother 2018; 52:910–919.
Bachert SE, Dogra P, Boral LI. Alternatives to transfusion. Am J Clin Pathol 2020; 153:287–293.
Castro CI, Briceno JC. Perfluorocarbon-based oxygen carriers: review of products and trials. Artif Organs 2010; 34:622–634.
Misra H, Bainbridge J, Berryman J, et al. A Phase Ib open label, randomized, safety study of SANGUINATE TM in patients with sickle cell anemia. Rev Bras Hematol Hemoter 2017; 39:20–27.
Brotman I, Kocher M, McHugh S. Bovine hemoglobin-based oxygen carrier treatment in a severely anemic Jehovah's Witness patient after cystoprostatectomy and nephrectomy: a case report. A A Pract 2019; 12:243–245.
Gomez MF, Aljure O, Ciancio G, Lynn M. Hemoglobin-based oxygen carrier rescues double-transplant patient from life-threatening anemia. Am J Transplant 2017; 17:1941–1944.
Vadehra D, Davino T, Datta D. Treating a patient with your hands tied: acute chest syndrome in a Jehovah's Witness. Cureus 2020; 12:e7769.